#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Cardiomyopathy Demyelination Cluster headache Vulval cancer Chronic lymphocytic leukaemia Hodgkin's disease recurrent Pustular psoriasis Hereditary optic atrophy Ewing's sarcoma Rheumatoid arthritis Malignant neoplasm of choroid Transient ischaemic attack Glycogen storage disease type I Fallopian tube cancer More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Hepatic angiosarcoma – Basic Information Chordoma Andersen-Tawil syndrome – Life with Disease Mucopolysaccharidosis Lymphangiosarcoma – Trials in Disease Chordoma – Treatment Optic glioma – Diagnostics Adrenogenital syndrome – Treatment Angiosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    D-Camphor Vinorelbine Tartrate Dutasteride 10-1074-Ls Etranacogene Dezaparvovec Retinol Acetate Hydroxyzine Hydrochloride Elebsiran Azd4831 Vsf1.01 Cln-081 Crizanlizumab Potassium Oxybate IBUZATRELVIR Filgotinib PAPAVERINE HYDROCHLORIDE MAGNESIUM ACETATE TETRAHYDRATE ISPAGHULA HUSK Satralizumab Posdinemab More therapies…

    Learn about Your Condition

    Small fibre neuropathy Liver transplant Upper limb fracture Proteus syndrome Breast cancer stage III Angiosarcoma metastatic Acute lymphocytic leukaemia Genital infection female Adenocarcinoma pancreas Congenital ureteric anomaly Urticaria cholinergic Skin neoplasm excision Testis cancer Post-traumatic headache Hip arthroplasty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    Investigated Drugs:
    • Azd8205
    • Doxorubicin
    • Paclitaxel
    Austria Belgium Czechia Denmark Finland France +9

  • A study of guanabenz acetate for children with vanishing white matter disease who started treatment in early childhood

    Recruiting

    1 1 1
    Investigated Drugs:
    • Guanabenz Acetate
    The Netherlands

  • A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Teplizumab
    Belgium Czechia France Germany Greece Italy +4

  • A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiomyopathy
    • Hypertrophic cardiomyopathy
    Austria Belgium France Germany Italy The Netherlands +3

  • Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Gemcitabine
    • Cisplatin
    • Pembrolizumab
    The Netherlands

  • A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • AB521
    • Cabozantinib
    • Placebo
    Czechia France Germany Italy The Netherlands Poland +2
Previous Page
1 … 101 102 103 104 105 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!